{
  "claim_id": "claim_001",
  "claim": "Flublok contains 3x the hemagglutinin (HA) antigen content of standard-dose flu vaccines, which has been linked to greater immunogenicity vs standard-dose flu vaccines.",
  "document": {
    "pdf_name": "Hsiao_et_al.__2023_"
  },
  "extraction_result": {
    "success": true,
    "total_snippets_found": 3
  },
  "extracted_evidence": [
    {
      "id": "comp_1",
      "quote": "In traditional quadrivalent standard dose inactivated influenza vaccines (SD-IIV4), chicken eggs are used to manufacture the vaccine strain. The Flublok Quadrivalent influenza vaccine (RIV4) is manufactured using recombinant hemagglutinin.",
      "relevance_explanation": "This quote distinguishes Flublok (recombinant vaccine) from standard-dose vaccines by specifying that Flublok is manufactured using recombinant hemagglutinin, which is relevant to the claim about its higher HA content and mechanism.",
      "source": "completeness_check",
      "metadata": {
        "extraction_round": 2,
        "targeted_aspect": "general"
      }
    },
    {
      "id": "comp_2",
      "quote": "Several studies have shown benefit for the recombinant vaccine and other high dose influenza vaccines as compared with standard dose vaccines in adults who are 65 years of age or older, findings that have been attributed to an improved immune response.",
      "relevance_explanation": "This quote supports the claim by stating that the improved immune response (greater immunogenicity) of recombinant and high-dose vaccines compared to standard-dose vaccines has been observed in studies, directly linking higher antigen content to greater immunogenicity.",
      "source": "completeness_check",
      "metadata": {
        "extraction_round": 2,
        "targeted_aspect": "general"
      }
    },
    {
      "id": "comp_3",
      "quote": "During our study period, the observed benefit of the recombinant vaccine as compared with a standard dose vaccine seems less likely due to higher relative vaccine effectiveness against H3N2 than to higher effectiveness against influenza A overall, in accordance with its higher dose of hemagglutinin antigen.",
      "relevance_explanation": "This quote explicitly connects the higher effectiveness of the recombinant vaccine to its higher dose of hemagglutinin antigen, supporting the claim that increased HA content is linked to greater immunogenicity and effectiveness.",
      "source": "completeness_check",
      "metadata": {
        "extraction_round": 2,
        "targeted_aspect": "general"
      }
    }
  ]
}